AAPL331.90-6.42 (-1.90%) ▼|ABBV286.00-2.84 (-0.98%) ▼|ABT109.38-0.79 (-0.71%) ▼|ACN253.96-6.98 (-2.67%) ▼|ADBE246.54-4.93 (-1.96%) ▼|AMAT380.13+5.60 (+1.50%) ▲|AMD487.46+20.62 (+4.42%) ▲|AMGN462.18-3.27 (-0.70%) ▼|AMT186.75-1.56 (-0.83%) ▼|AMZN251.85+6.22 (+2.53%) ▲|AVGO332.31+10.08 (+3.13%) ▲|AXP325.48-2.50 (-0.76%) ▼|BA173.84-1.56 (-0.89%) ▼|BAC49.62+0.05 (+0.09%) ▲|BKNG152.99-0.76 (-0.49%) ▼|BLK1,161.75-5.40 (-0.46%) ▼|BMY61.89-1.13 (-1.79%) ▼|BNY150.05+2.27 (+1.53%) ▲|BRK-B557.29+1.18 (+0.21%) ▲|C122.28-0.82 (-0.67%) ▼|CAT622.20+8.58 (+1.40%) ▲|CL95.64-1.79 (-1.84%) ▼|CMCSA23.65-0.22 (-0.92%) ▼|COF208.58-2.20 (-1.04%) ▼|COP144.38-2.47 (-1.68%) ▼|COST1,023.72-16.83 (-1.62%) ▼|CRM222.43-3.76 (-1.66%) ▼|CSCO103.00+1.39 (+1.37%) ▲|CVS91.47+2.96 (+3.34%) ▲|CVX225.64-2.13 (-0.94%) ▼|DE669.04+1.44 (+0.22%) ▲|DHR230.60+2.63 (+1.15%) ▲|DIS114.17+1.06 (+0.94%) ▲|DUK126.83-1.55 (-1.21%) ▼|EMR166.39+0.43 (+0.26%) ▲|FDX320.51+2.26 (+0.71%) ▲|GD373.13-0.34 (-0.09%) ▼|GE320.46+4.68 (+1.48%) ▲|GEV917.26+55.01 (+6.38%) ▲|GILD169.12-1.21 (-0.71%) ▼|GM88.35-1.60 (-1.77%) ▼|GOOG277.52-0.53 (-0.19%) ▼|GOOGL278.86-0.14 (-0.05%) ▼|GS897.27-1.45 (-0.16%) ▼|HD331.71-9.44 (-2.77%) ▼|HON223.56-0.22 (-0.10%) ▼|IBM249.12-3.39 (-1.34%) ▼|INTC60.22+0.25 (+0.42%) ▲|INTU347.67-4.43 (-1.26%) ▼|ISRG442.49+5.62 (+1.29%) ▲|JNJ266.78-3.78 (-1.40%) ▼|JPM337.55-3.03 (-0.89%) ▼|KO94.94-0.90 (-0.93%) ▼|LIN513.99-5.73 (-1.10%) ▼|LLY1,412.68+1.69 (+0.12%) ▲|LMT642.64-0.51 (-0.08%) ▼|LOW212.97-5.18 (-2.37%) ▼|LRCX229.16+1.60 (+0.70%) ▲|MA648.25-9.85 (-1.50%) ▼|MCD262.81-2.83 (-1.07%) ▼|MDLZ65.39-0.99 (-1.49%) ▼|MDT98.94-0.35 (-0.35%) ▼|META619.31+12.58 (+2.07%) ▲|MMM176.84-1.53 (-0.86%) ▼|MO76.76-0.41 (-0.53%) ▼|MRK143.71-4.65 (-3.13%) ▼|MS186.62+0.89 (+0.48%) ▲|MSFT522.83+15.71 (+3.10%) ▲|MU850.72+17.13 (+2.06%) ▲|NEE84.14-0.90 (-1.05%) ▼|NFLX62.95+0.61 (+0.98%) ▲|NKE38.23-0.90 (-2.29%) ▼|NOW108.33+2.32 (+2.19%) ▲|NVDA206.89+4.83 (+2.39%) ▲|ORCL125.32+6.10 (+5.12%) ▲|PEP137.50-2.93 (-2.08%) ▼|PFE30.02-0.65 (-2.13%) ▼|PG162.04-1.53 (-0.93%) ▼|PLTR175.87-2.48 (-1.39%) ▼|PM208.30+0.01 (+0.00%) ▲|QCOM164.06+1.98 (+1.22%) ▲|RTX203.81+1.02 (+0.50%) ▲|SBUX104.19-0.22 (-0.21%) ▼|SCHW89.01+0.30 (+0.34%) ▲|SO93.85-0.76 (-0.80%) ▼|SPG221.54-0.20 (-0.09%) ▼|T21.25-0.20 (-0.91%) ▼|TMO699.45+16.80 (+2.46%) ▲|TMUS154.42-5.74 (-3.58%) ▼|TSLA398.16-5.66 (-1.40%) ▼|TXN311.79+9.77 (+3.23%) ▲|UBER66.78+0.07 (+0.10%) ▲|UNH401.78+1.34 (+0.33%) ▲|UNP305.23-1.77 (-0.58%) ▼|UPS109.14-0.57 (-0.52%) ▼|USB59.96-0.53 (-0.88%) ▼|V421.18-4.34 (-1.02%) ▼|VZ45.05-0.01 (-0.01%) ▼|WFC85.43-0.47 (-0.54%) ▼|WMT124.74-2.95 (-2.31%) ▼|XOM177.88-1.79 (-1.00%) ▼|AAPL331.90-6.42 (-1.90%) ▼|ABBV286.00-2.84 (-0.98%) ▼|ABT109.38-0.79 (-0.71%) ▼|ACN253.96-6.98 (-2.67%) ▼|ADBE246.54-4.93 (-1.96%) ▼|AMAT380.13+5.60 (+1.50%) ▲|AMD487.46+20.62 (+4.42%) ▲|AMGN462.18-3.27 (-0.70%) ▼|AMT186.75-1.56 (-0.83%) ▼|AMZN251.85+6.22 (+2.53%) ▲|AVGO332.31+10.08 (+3.13%) ▲|AXP325.48-2.50 (-0.76%) ▼|BA173.84-1.56 (-0.89%) ▼|BAC49.62+0.05 (+0.09%) ▲|BKNG152.99-0.76 (-0.49%) ▼|BLK1,161.75-5.40 (-0.46%) ▼|BMY61.89-1.13 (-1.79%) ▼|BNY150.05+2.27 (+1.53%) ▲|BRK-B557.29+1.18 (+0.21%) ▲|C122.28-0.82 (-0.67%) ▼|CAT622.20+8.58 (+1.40%) ▲|CL95.64-1.79 (-1.84%) ▼|CMCSA23.65-0.22 (-0.92%) ▼|COF208.58-2.20 (-1.04%) ▼|COP144.38-2.47 (-1.68%) ▼|COST1,023.72-16.83 (-1.62%) ▼|CRM222.43-3.76 (-1.66%) ▼|CSCO103.00+1.39 (+1.37%) ▲|CVS91.47+2.96 (+3.34%) ▲|CVX225.64-2.13 (-0.94%) ▼|DE669.04+1.44 (+0.22%) ▲|DHR230.60+2.63 (+1.15%) ▲|DIS114.17+1.06 (+0.94%) ▲|DUK126.83-1.55 (-1.21%) ▼|EMR166.39+0.43 (+0.26%) ▲|FDX320.51+2.26 (+0.71%) ▲|GD373.13-0.34 (-0.09%) ▼|GE320.46+4.68 (+1.48%) ▲|GEV917.26+55.01 (+6.38%) ▲|GILD169.12-1.21 (-0.71%) ▼|GM88.35-1.60 (-1.77%) ▼|GOOG277.52-0.53 (-0.19%) ▼|GOOGL278.86-0.14 (-0.05%) ▼|GS897.27-1.45 (-0.16%) ▼|HD331.71-9.44 (-2.77%) ▼|HON223.56-0.22 (-0.10%) ▼|IBM249.12-3.39 (-1.34%) ▼|INTC60.22+0.25 (+0.42%) ▲|INTU347.67-4.43 (-1.26%) ▼|ISRG442.49+5.62 (+1.29%) ▲|JNJ266.78-3.78 (-1.40%) ▼|JPM337.55-3.03 (-0.89%) ▼|KO94.94-0.90 (-0.93%) ▼|LIN513.99-5.73 (-1.10%) ▼|LLY1,412.68+1.69 (+0.12%) ▲|LMT642.64-0.51 (-0.08%) ▼|LOW212.97-5.18 (-2.37%) ▼|LRCX229.16+1.60 (+0.70%) ▲|MA648.25-9.85 (-1.50%) ▼|MCD262.81-2.83 (-1.07%) ▼|MDLZ65.39-0.99 (-1.49%) ▼|MDT98.94-0.35 (-0.35%) ▼|META619.31+12.58 (+2.07%) ▲|MMM176.84-1.53 (-0.86%) ▼|MO76.76-0.41 (-0.53%) ▼|MRK143.71-4.65 (-3.13%) ▼|MS186.62+0.89 (+0.48%) ▲|MSFT522.83+15.71 (+3.10%) ▲|MU850.72+17.13 (+2.06%) ▲|NEE84.14-0.90 (-1.05%) ▼|NFLX62.95+0.61 (+0.98%) ▲|NKE38.23-0.90 (-2.29%) ▼|NOW108.33+2.32 (+2.19%) ▲|NVDA206.89+4.83 (+2.39%) ▲|ORCL125.32+6.10 (+5.12%) ▲|PEP137.50-2.93 (-2.08%) ▼|PFE30.02-0.65 (-2.13%) ▼|PG162.04-1.53 (-0.93%) ▼|PLTR175.87-2.48 (-1.39%) ▼|PM208.30+0.01 (+0.00%) ▲|QCOM164.06+1.98 (+1.22%) ▲|RTX203.81+1.02 (+0.50%) ▲|SBUX104.19-0.22 (-0.21%) ▼|SCHW89.01+0.30 (+0.34%) ▲|SO93.85-0.76 (-0.80%) ▼|SPG221.54-0.20 (-0.09%) ▼|T21.25-0.20 (-0.91%) ▼|TMO699.45+16.80 (+2.46%) ▲|TMUS154.42-5.74 (-3.58%) ▼|TSLA398.16-5.66 (-1.40%) ▼|TXN311.79+9.77 (+3.23%) ▲|UBER66.78+0.07 (+0.10%) ▲|UNH401.78+1.34 (+0.33%) ▲|UNP305.23-1.77 (-0.58%) ▼|UPS109.14-0.57 (-0.52%) ▼|USB59.96-0.53 (-0.88%) ▼|V421.18-4.34 (-1.02%) ▼|VZ45.05-0.01 (-0.01%) ▼|WFC85.43-0.47 (-0.54%) ▼|WMT124.74-2.95 (-2.31%) ▼|XOM177.88-1.79 (-1.00%) ▼|
18.5 C
New York
Tuesday, November 3, 2026

Tag: site

newsFORsourcecompanycontentinformationreleases1market

En termes d’efficacité, une comparaison indirecte des traitements suggère un avantage significatif d’IMBRUVICA® (ibrutinib) associé au vénétoclax par rapport à l’acalabrutinib associé au vénétoclax...

Les résultats d’études croisées de l’association ibrutinib et vénétoclax en première intention montrent un bénéfice clinique significatif pour une durée fixe, ainsi qu’une probabilité accrue de maladie résiduelle minimale indétectable et de survie sans progression par rapport à l’association acalabrutinib et vénétoclax1

Shasqi Publishes Landmark Study in Clinical Cancer Research: First-in-Human Use of Click Chemistry Unlocks New Opportunities for Targeted Cancer Therapies

Shasqi is a leader in the translational application of click chemistry, a Nobel Prize winning technology, and the first company to use this technology in...

Golden Gas Announces Open Season for Joy Station Storage Project in Kansas

TULSA, Okla., June 16, 2025 /PRNewswire/ -- Golden Gas Service Company ("Golden Gas") today announced the launch of a non-binding open season to solicit market...

RAPPEL : Boralex tiendra une Journée de l’investisseur et présentera sa Stratégie 2030 le 17 juin 2025

MONTRÉAL, 16 juin 2025 (GLOBE NEWSWIRE) -- Boralex inc. (« Boralex » ou la « Société ») (TSX : BLX) annonce que sa Stratégie 2030 sera présenté dans le cadre d’une Journée de l’investisseur le 17 juin 2025, de 10 h à 12 h 30, à Toronto.

The Fastest Growing Beauty Brand is Turning Beauty’s Dirty Water Into Clean Water for Africa

LOS ANGELES, June 16, 2025 /PRNewswire/ -- The clean beauty movement is setting a new standard: waterless. With global water scarcity reaching critical proportions,...

New Again Houses® Welcomes New Cash Home Buyers in Billings, MT

Multi-Faceted Real Estate Business Celebrates Continued Success with the Opening of Its 57th Cash Home Buying Franchise in Billings, MT 
Multi-Faceted Real Estate Business Celebrates Continued Success with the Opening of Its 57th Cash Home Buying Franchise in Billings, MT

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) and HOPE Therapeutics, Inc. Announce Strategic Investor Relations Partnership with astr partners

WILMINGTON, Del., June 16, 2025 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", "NRx" or the "Company"), a clinical-stage biopharmaceutical company, and HOPE...

Driving emissions transparency: INEOS Styrolution rolls out product carbon footprint calculations across global portfolio

PCF platform automates product carbon footprint calculations and enables customer monitoring of scope 3.1 emissions for INEOS Styrolution productsMethodology certified by TÜV Rheinland and...

T1 Energy Advances $850 Million Planned 5 GW Solar Cell Plant

T1 Energy announces significant progress towards $850 million, 5 GW solar cell facility.

June 17, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NPWR

NEW YORK, June 16, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of NET Power, Inc. (NYSE: NPWR). ...

ITM and ILL Extend Collaboration on the Manufacturing and Supply of Medical Lutetium-177 Radioisotope

Garching / Munich, Germany, and Grenoble, France, June 16, 2025 – ITM Isotope Technologies Munich SE (ITM) and the Institut Laue-Langevin (ILL), today announced an extension of their collaboration for medical radioisotope production, originally established in 2009. Under the terms of the renewed agreement, ITM will receive priority access to half of the available neutron irradiation capacity at ILL’s High-Flux Reactor, its neutron irradiation facility, for the production of non-carrier-added Lutetium-177 (n.c.a. Lu-177), a critical medical radioisotope used for radiopharmaceutical therapies for cancer treatment and diagnosis. As the globally leading manufacturer of n.c.a. Lu-177, ITM is committed to maintaining and expanding its robust manufacturing and production capabilities to meet the growing demand for this vital medical radioisotope.

GLOBAL MANCOZEB SUMMIT: ADDRESSING ITS CRUCIAL ROLE IN CROP PROTECTION AHEAD OF EU COURT HEARING

LONDON, June 16, 2025 /PRNewswire/ -- UPL Corporation Ltd. (UPL Corp) - part of UPL Group Company (NSE: UPL) & (BSE: 512070) (LSE: UPL), a...

Global Times: Cultural inheritance must touch the heart first

BEIJING, June 15, 2025 /PRNewswire/ -- Dunhuang, with its millennia-old heritage, is finding new life through the energy and creativity of young people. Over...

SDP Japan Raises $31 Million in Series D Round

Pioneering the Future of Surgical Care in Response to Rising DemandTOKYO, June 15, 2025 /PRNewswire/ -- SDP Japan, Inc. (Shibuya-ku, Tokyo; CEO: Kazuhiko Nagayo),...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSite

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers